'Just 15% better would be a vast improvement': Alzheimer's walk fights disease that may reach one in four Americans

Biogen will make a second attempt to win FDA approval for a new Alzheimer's treatment.
The move could be aimed at protecting investors, who helped him buy purchase X, from losing money. from BBC News https://ift.tt/upf7MHS
0 comments:
Post a Comment